Skip to main content
Cardiovascular Diseases logoLink to Cardiovascular Diseases
. 1981 Mar;8(1):23–28.

Intraaortic administration of protamine: Method for heparin neutralization after cardiopulmonary bypass

Alejandro Aris, Heriberto Solanes, Jose O Bonnin, Rosa Garin, Jose M Caralps
PMCID: PMC287895  PMID: 15216222

Abstract

In neutralizing heparin with intravenous protamine sulfate, hypotension may be prevented by administering the drug intraarterially. Forty patients underwent cardiac surgery with extracorporeal circulation in our hospital; each received a rapid injection of nondiluted protamine sulfate in the aortic root to reverse the effects of heparin. To maintain the blood volume at a constant level, volume expanders and inotropic drugs were avoided.

The intraaortic injections ranged in duration from 0.2 min to 2.8 min, with a mean of 1.1 min. The mean systolic pressure only dropped from 92 mm Hg (SD ± 21) before protamine injection to 85 mm Hg (SD ± 23) after injection (p < 0.0001). In seven patients (18%), no hypotension was evident; in the remaining patients, the systolic pressure returned to preinjection values within a mean of 2.2 min. Coagulation was observed within 3 to 4 min (mean = 2.2 min) after the initiation of injection.

This study indicates that intraaortic administration of protamine is a rapid and safe technique for heparin reversal after cardiopulmonary bypass.

Full text

PDF
23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bull B. S., Korpman R. A., Huse W. M., Briggs B. D. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg. 1975 May;69(5):674–684. [PubMed] [Google Scholar]
  2. EGERTON W. S., ROBINSON C. L. The anti-heparin, anticoagulant and hypotensive properties of hexadimethrine and protamine. Lancet. 1961 Sep 16;2(7203):635–637. doi: 10.1016/s0140-6736(61)90311-7. [DOI] [PubMed] [Google Scholar]
  3. Ellison N., Beatty C. P., Blake D. R., Wurzel H. A., MacVaugh H., 3rd Heparin rebound. Studies in patients and volunteers. J Thorac Cardiovasc Surg. 1974 May;67(5):723–729. [PubMed] [Google Scholar]
  4. Goldman B. S., Joison J., Austen W. G. Cardiovascular effects of protamine sulfate. Ann Thorac Surg. 1969 May;7(5):459–471. doi: 10.1016/s0003-4975(10)66210-8. [DOI] [PubMed] [Google Scholar]
  5. Gourin A., Streisand R. L., Greineder J. K., Stuckey J. H. Protamine sulfate administration and the cardiovascular system. J Thorac Cardiovasc Surg. 1971 Aug;62(2):193–204. [PubMed] [Google Scholar]
  6. Gourin A., Streisand R. L., Stuckey J. H. Total cardiopulmonary bypass, myocardial contractility, and the administration of protamine sulfate. J Thorac Cardiovasc Surg. 1971 Jan;61(1):160–166. [PubMed] [Google Scholar]

Articles from Cardiovascular Diseases are provided here courtesy of Texas Heart Institute

RESOURCES